These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12124166)

  • 21. Heregulin regulation of urokinase plasminogen activator and its receptor: human breast epithelial cell invasion.
    Mazumdar A; Adam L; Boyd D; Kumar R
    Cancer Res; 2001 Jan; 61(1):400-5. PubMed ID: 11196194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated urokinase-type plasminogen activator receptor expression in a colon cancer cell line is due to a constitutively activated extracellular signal-regulated kinase-1-dependent signaling cascade.
    Lengyel E; Wang H; Gum R; Simon C; Wang Y; Boyd D
    Oncogene; 1997 May; 14(21):2563-73. PubMed ID: 9191056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paracrine stimulation of capillary endothelial cell migration by endometrial tissue involves epidermal growth factor and is mediated via up-regulation of the urokinase plasminogen activator receptor.
    Sandberg T; Ehinger A; Casslén B
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1724-30. PubMed ID: 11297609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidermal growth factor-induced nuclear factor kappa B activation: A major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells.
    Biswas DK; Cruz AP; Gansberger E; Pardee AB
    Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8542-7. PubMed ID: 10900013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A structural basis for differential cell signalling by PAI-1 and PAI-2 in breast cancer cells.
    Croucher DR; Saunders DN; Stillfried GE; Ranson M
    Biochem J; 2007 Dec; 408(2):203-10. PubMed ID: 17696882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of human squamous cell carcinoma plasma membrane associated urokinase plasminogen activator by epidermal growth factor.
    Niedbala MJ; Bajetta S; Carbone R; Sartorelli AC
    Cancer Commun; 1990; 2(9):317-24. PubMed ID: 2169831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RANK-c attenuates aggressive properties of ER-negative breast cancer by inhibiting NF-κB activation and EGFR signaling.
    Sirinian C; Papanastasiou AD; Schizas M; Spella M; Stathopoulos GT; Repanti M; Zarkadis IK; King TA; Kalofonos HP
    Oncogene; 2018 Sep; 37(37):5101-5114. PubMed ID: 29844572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The invasive phenotype in HMT-3522 cells requires increased EGF receptor signaling through both PI 3-kinase and ERK 1,2 pathways.
    Price DJ; Avraham S; Feuerstein J; Fu Y; Avraham HK
    Cell Commun Adhes; 2002; 9(2):87-102. PubMed ID: 12487410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. β-Heregulin impairs EGF induced PLC-γ1 signalling in human breast cancer cells.
    Rommerswinkel N; Keil S; Adawy A; Hengstler JG; Niggemann B; Zänker KS; Dittmar T
    Cell Signal; 2018 Dec; 52():23-34. PubMed ID: 30165102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasminogen activator inhibitor 1 functions as a urokinase response modifier at the level of cell signaling and thereby promotes MCF-7 cell growth.
    Webb DJ; Thomas KS; Gonias SL
    J Cell Biol; 2001 Feb; 152(4):741-52. PubMed ID: 11266465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of bone morphogenetic protein 6 in normal mammary tissue and breast cancer cell lines and its regulation by epidermal growth factor.
    Clement JH; Sänger J; Höffken K
    Int J Cancer; 1999 Jan; 80(2):250-6. PubMed ID: 9935207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of EGF/ERBB1 in the transcriptional regulation of the prolactin receptor independent of estrogen and prolactin in breast cancer cells.
    Kavarthapu R; Dufau ML
    Oncotarget; 2016 Oct; 7(40):65602-65613. PubMed ID: 27564112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidermal growth factor receptors in human breast cancer.
    Pérez R; Pascual M; Macías A; Lage A
    Breast Cancer Res Treat; 1984; 4(3):189-93. PubMed ID: 6091821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein kinase C mediates up-regulation of urokinase and its receptor in the migrating keratinocytes of wounded cultures, but urokinase is not required for movement across a substratum in vitro.
    Ando Y; Jensen PJ
    J Cell Physiol; 1996 Jun; 167(3):500-11. PubMed ID: 8655604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of the effects of epidermal growth factor on urokinase secretion and urokinase receptor display in a well-differentiated human colon carcinoma cell line.
    Boyd D; Brattain M
    Cancer Res; 1989 Apr; 49(8):1948-53. PubMed ID: 2539250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tyrosine kinase signalling in breast cancer: epidermal growth factor receptor and c-Src interactions in breast cancer.
    Biscardi JS; Ishizawar RC; Silva CM; Parsons SJ
    Breast Cancer Res; 2000; 2(3):203-10. PubMed ID: 11250711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of pS2 protein and receptors for epidermal growth factor (EGF-R), insulin-like growth factor-1 (IGF-1-R) and somatostatin (SS-R) in patients with breast and ovarian cancer.
    Foekens JA; van Putten WL; Portengen H; Rodenburg CJ; Reubi JC; Berns PM; Henzen-Logmans SC; van der Burg ME; Alexieva-Figusch J; Klijn JG
    J Steroid Biochem Mol Biol; 1990 Dec; 37(6):815-21. PubMed ID: 2178364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nipple aspirate fluid expression of urokinase-type plasminogen activator, plasminogen activator inhibitor-1, and urokinase-type plasminogen activator receptor predicts breast cancer diagnosis and advanced disease.
    Qin W; Zhu W; Wagner-Mann C; Sauter ER
    Ann Surg Oncol; 2003 Oct; 10(8):948-53. PubMed ID: 14527916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Down-regulation of epidermal growth factor receptor correlates with plasminogen activator activity in human A431 epidermoid carcinoma cells.
    Gross JL; Krupp MN; Rifkin DB; Lane MD
    Proc Natl Acad Sci U S A; 1983 Apr; 80(8):2276-80. PubMed ID: 6300905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidermal-growth-factor receptors and oestrogen receptors in human breast cancer.
    Sainsbury JR; Farndon JR; Sherbet GV; Harris AL
    Lancet; 1985 Feb; 1(8425):364-6. PubMed ID: 2857419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.